الدليل الوطني للأدوية المسجّلة في لبنان
تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان
يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم
الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| B01AB05 | ENOXAMED | BioTech | Enoxaparin sodium - 2000IU Anti-XA/0.2ml | 2000IU Anti-XA/0.2ml | Injectable solution | 1105982.3775 |
| B01AB05 | ENOXAMED | BioTech | Enoxaparin sodium - 2000IU Anti-XA/0.2ml | 2000IU Anti-XA/0.2ml | Injectable solution | 388370.4825 |
| B01AB05 | LOVENOX | BioTech | Enoxaparin sodium - 2,000UI (20mg)/0.2ml | 2,000UI (20mg)/0.2ml | Injectable solution | 467657.19 |
| B01AB05 | PARINOX 20 | BioTech | Enoxaparin sodium - 2000IU (20mg)/0.2ml | 2000IU (20mg)/0.2ml | Injectable solution | 188137.95 |
| B01AB05 | ENOXAMED | BioTech | Enoxaparin sodium - 10000IU Anti-XA/1ml | 10000IU Anti-XA/1ml | Injectable solution | 1209458.25 |
| B01AB01 | HEPARINE MEDIS | G | Heparin sodium - 25,000UI/5ml | 25,000UI/5ml | Injectable solution | 6853596.75 |
| B01AB01 | HEPARINE SODIQUE PANPHARMA | G | Heparin sodium - 25,000IU/5ml | 25,000IU/5ml | Injectable solution | 6134641.0125 |
| B01AA07 | SINTROM | B | Acenocoumarol - 4mg | 4mg | Tablet | 490182.55 |
| A16AX | BICANORM | G | Sodium bicarbonate - 1000mg | 1000mg | Tablet, gastroresistant | 2623180.56 |
| A16AB07 | MYOZYME | BioTech | Alglucosidase alfa, recombinant human acid - 50mg | 50mg | Injectable powder for concentrate for solution | |
| A16AB07 | MYOZYME | BioTech | Alglucosidase alfa, recombinant human acid - 50mg | 50mg | Injectable powder for concentrate for solution | 56536307.183606 |
| A16AB05 | ALDURAZYME | B | Laronidase - 100U/ml | 100U/ml | Injectable concentrate for solution | 57138679.5 |
| A16AB04 | FABRAZYME | BioTech | Agalsidase beta - 35mg | 35mg | Injectable powder for concentrate for solution | |
| A16AB04 | FABRAZYME | BioTech | Agalsidase beta - 35mg | 35mg | Injectable powder for concentrate for solution | 295038213.35297 |
| A16AB02 | CEREZYME | B | Imiglucerase - 400IU | 400IU | Injectable lyophilised powder for solution | |
| A16AB02 | CEREZYME | B | Imiglucerase - 400IU | 400IU | Injectable lyophilised powder for solution | 128412817.71937 |
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
